Search research articles
Contact Us
Filters
Showing results (181-190 of 235) with videos related to
Page
of 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2023
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
Rohit Thummalapalli, Biagio Ricciuti, Chaitanya Bandlamudi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2017
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
Leora Horn, David R Spigel, Everett E Vokes, et al.
Cancer Discovery
|
September 1, 2022
Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort
Kanika Arora, Thinh N Tran, Yelena Kemel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2016
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
Jarushka Naidoo, Xuan Wang, Kaitlin M Woo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 23, 2019
Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC
Scott J Antonia, Ani Balmanoukian, Julie Brahmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 17, 2018
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing
Hira Rizvi, Francisco Sanchez-Vega, Konnor La, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2019
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
K Hastings, H A Yu, W Wei, et al.
Cancer Immunology Research
|
December 18, 2023
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
Arielle Elkrief, Nicholas R Waters, Natalie Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 21, 2020
COVID-19 in patients with lung cancer
J Luo, H Rizvi, I R Preeshagul, et al.
Nature
|
May 31, 2022
Author Correction: Fundamental immune-oncogenicity trade-offs define driver mutation fitness
David Hoyos, Roberta Zappasodi, Isabell Schulze, et al.
Page
of 24
Search research articles
Search
Showing results (181-190 of 235) with videos related to
Sort By:
Page
of 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2023
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
Rohit Thummalapalli, Biagio Ricciuti, Chaitanya Bandlamudi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2017
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
Leora Horn, David R Spigel, Everett E Vokes, et al.
Cancer Discovery
|
September 1, 2022
Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort
Kanika Arora, Thinh N Tran, Yelena Kemel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2016
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
Jarushka Naidoo, Xuan Wang, Kaitlin M Woo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 23, 2019
Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC
Scott J Antonia, Ani Balmanoukian, Julie Brahmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 17, 2018
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing
Hira Rizvi, Francisco Sanchez-Vega, Konnor La, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2019
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
K Hastings, H A Yu, W Wei, et al.
Cancer Immunology Research
|
December 18, 2023
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
Arielle Elkrief, Nicholas R Waters, Natalie Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 21, 2020
COVID-19 in patients with lung cancer
J Luo, H Rizvi, I R Preeshagul, et al.
Nature
|
May 31, 2022
Author Correction: Fundamental immune-oncogenicity trade-offs define driver mutation fitness
David Hoyos, Roberta Zappasodi, Isabell Schulze, et al.
Page
of 24